Citadel Advisors
ISLE

Citadel Advisors’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Citadel Advisors’s Portfolio ISLE Stock Details ISLE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,211
Closed -$169K – 15133
2021
Q4 		$169K Buy
17,211
+6,196
+56% +$60.9K ﹤0.01% 12111
2021
Q3 		$108K Buy
+11,015
New +$107K ﹤0.01% 12787
2021
Q2 		– Sell
-12,192
Closed -$118K – 14781
2021
Q1 		$118K Buy
+12,192
New +$118K ﹤0.01% 12329

Other funds holding ISLE

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Citadel Advisors's ISLE Position: Q1 2022 in Review

Citadel Advisors sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q1 2022, closing a stake of 17,211 shares — an estimated $169K sold.

Citadel Advisors first reported a position in ISLE in Q1 2021 and held it in 3 quarters. The position peaked at $169K in Q4 2021. 69 funds tracked by Wall St. Rank hold ISLE as of Q1 2022.

  • Citadel Advisors reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 17,211 Isleworth Healthcare Acquisition Corporation Common stock shares in Q1 2022, an estimated $169K.
  • Citadel Advisors first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 3 quarters.
  • Citadel Advisors's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $169K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.